Cryopyrin Associated Periodic Syndrome clinical trials

Explore recruiting cryopyrin associated periodic syndrome clinical trials.

Recruiting cryopyrin associated periodic syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cryopyrin Associated Periodic Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study investigating the safety, absorption, and elimination of NT 0150, a new compound that may potentially be used in the treatment of brain disorders, like Alzheimer’s disease and Parkinson’s disease.

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Cryopyrin Associated Periodic Syndrome trials by city

Cryopyrin Associated Periodic Syndrome in Toronto Cryopyrin Associated Periodic Syndrome in Vancouver Cryopyrin Associated Periodic Syndrome in Montreal Cryopyrin Associated Periodic Syndrome in Calgary Cryopyrin Associated Periodic Syndrome in Edmonton Cryopyrin Associated Periodic Syndrome in Ottawa Cryopyrin Associated Periodic Syndrome in Winnipeg Cryopyrin Associated Periodic Syndrome in Quebec City Cryopyrin Associated Periodic Syndrome in Hamilton Cryopyrin Associated Periodic Syndrome in Kitchener Cryopyrin Associated Periodic Syndrome in London Cryopyrin Associated Periodic Syndrome in Halifax Cryopyrin Associated Periodic Syndrome in New York Cryopyrin Associated Periodic Syndrome in Los Angeles Cryopyrin Associated Periodic Syndrome in Chicago Cryopyrin Associated Periodic Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease